Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you feel unwell on your usual injection day, the instinct to skip the dose is understandable — but for most illnesses it is the wrong call. Taking Wegovy while sick depends heavily on what kind of sick: a mild cold is a different situation from persistent vomiting or severe diarrhoea. As a prescription-only medicine, any meaningful change to how you use it should be discussed with your prescriber rather than decided in the moment. This page works through the evidence and gives you a clear picture of what to do — and when to get help fast.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception is that feeling unwell automatically means Wegovy should pause. That is not what clinical guidance says. For mild, self-limiting illnesses (a cold, a sore throat, a low-grade fever with no significant vomiting or diarrhoea) there is no established reason to skip your weekly dose. Semaglutide's mechanism (slowing gastric emptying and acting on GLP-1 receptors to reduce appetite) does not interact harmfully with a blocked nose or a headache. The injection is subcutaneous, so it bypasses the gut entirely and reaches the bloodstream regardless of how your stomach feels on a given day.
Where it gets more complicated is gastrointestinal illness. Semaglutide already causes nausea in many people, particularly after starting or after a dose increase, something covered in more depth on the full Wegovy side effects overview. Add a stomach bug, food poisoning or norovirus, and the combined effect can be severe. That is the scenario where clinical judgement genuinely matters, and where the guidance shifts.
The short version: mild illness, carry on and monitor. Significant vomiting, persistent diarrhoea, or signs of dehydration, reassess, and probably speak to a clinician that day.
The MHRA issued a Drug Safety Update in January 2026 highlighting dehydration-related kidney injury as a known risk with GLP-1 receptor agonists during acute gastrointestinal illness. The mechanism is straightforward: vomiting and diarrhoea deplete fluid and electrolytes; semaglutide can amplify GI symptoms; and reduced kidney perfusion from dehydration is a documented consequence. This is not a theoretical concern, it is why the guidance exists.
If you are already experiencing significant vomiting on Wegovy (which is a recognised side effect, particularly early in treatment), illness that adds more can tip things toward dehydration quickly. Patients moving to the 1ml dose often find this is worth reviewing in detail, and the guide to Wegovy 1ml side effects covers what to expect at that stage and when symptoms warrant attention. The practical rule from the NHS is to stay hydrated with small, frequent sips of water or oral rehydration solution, rest, and stop eating until the vomiting settles, but if you cannot keep fluids down for more than 24 hours, get medical advice.
Constipation during illness is a separate issue, if Wegovy has already slowed your gut and a bout of illness leaves you immobile and eating less, things can compound. The page on constipation while on Wegovy has practical detail on what is generally considered safe to use alongside semaglutide.
If you decide (or are advised) to delay a dose because of illness, the timing rule is in your Patient Information Leaflet and the NHS semaglutide medicines page: if your usual injection day has passed and the next dose is more than 48 hours away, you can take it late. If the next scheduled dose is within 48 hours, skip the missed dose and resume your normal schedule. Never double up. These rules exist to maintain steady drug levels while avoiding dose stacking.
One thing worth planning around: if your injection day falls on a bank holiday week or you are away and your pen is travelling with you, knowing where your doses stand matters more than usual. If you are unsure, a quick message to your prescriber's aftercare team is the sensible move rather than guessing. The Wegovy treatment overview covers storage and travel considerations that are easy to underestimate when you are already feeling rough.
On the cost side, if illness means a dose is wasted or a delivery needs to be held, it is worth knowing exactly what is included in your treatment arrangement. The context around Wegovy pricing in the UK explains what legitimate providers typically include and what can catch patients out.
Some symptoms during illness require same-day attention, regardless of whether they feel connected to your Wegovy. Seek urgent medical help if you experience: severe stomach pain that spreads to your back (a potential sign of pancreatitis, which the MHRA Yellow Card reporting scheme and clinical teams take seriously as a rare but recognised GLP-1 risk); signs of significant dehydration such as very dark urine, dizziness on standing, or an inability to keep any fluid down; or any allergic reaction, swelling, difficulty breathing, rapid heart rate. These are not situations to manage with rest and fluids.
For anything less acute (persistent nausea that is worsening your illness, uncertainty about whether to take your next dose, or concern about a new symptom) your prescriber's aftercare support is the appropriate first step. Trying to work it out from a search engine when you are feeling rough rarely ends well. If you are considering starting semaglutide and want to understand how the clinical review process works, you can speak to our prescribers through a free consultation to go through your health picture properly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.